The emergence of immune checkpoint inhibitors, such as anti-PDL-1, anti-PD-1, and anti-CTLA-4, which have good efficacy in many tumor models [20], raises the question of the pertinence and safety of their combination with radiation. This evidence concerns the gene CD274 and neoplasm.